VKH
RGLS

Virtu KCG Holdings’s Regulus Therapeutics RGLS Stock Holding History

Virtu KCG Holdings’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$26K Buy
+222
New +$37.1K ﹤0.01% 2696
2017
Q1 		– Sell
-547
Closed -$148K – 3643
2016
Q4 		$148K Buy
547
+455
+495% +$148K ﹤0.01% 2755
2016
Q3 		$37K Sell
92
-583
-86% -$240K ﹤0.01% 2831
2016
Q2 		$234K Buy
675
+505
+297% +$362K ﹤0.01% 2159
2016
Q1 		$142K Buy
+170
New +$135K ﹤0.01% 2229
2015
Q4 		– Sell
-103
Closed -$81K – 3862
2015
Q3 		$81K Sell
103
-27
-21% -$27.7K ﹤0.01% 2887
2015
Q2 		$171K Buy
+130
New +$210K ﹤0.01% 2683

Other funds holding RGLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Virtu KCG Holdings's RGLS Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Regulus Therapeutics (RGLS) in Q2 2017: 222 shares worth $26K. The stake represents ﹤0.01% of the portfolio and ranks #2696 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in RGLS as recently as Q4 2016.

Virtu KCG Holdings first reported a position in RGLS in Q2 2015 and has held it in 7 quarters since. The position peaked at $234K in Q2 2016. 46 funds tracked by Wall St. Rank hold RGLS as of Q2 2017.

  • Virtu KCG Holdings held 222 shares of Regulus Therapeutics worth $26K as of Q2 2017.
  • Regulus Therapeutics was a new Virtu KCG Holdings position in Q2 2017.
  • Regulus Therapeutics made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2696 holding.
  • Virtu KCG Holdings first reported a position in Regulus Therapeutics in Q2 2015 and has held it in 7 quarters since.
  • Virtu KCG Holdings's Regulus Therapeutics position peaked at $234K in Q2 2016.
  • 46 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.